Mixed
Bariatric surgery significantly reduces overall mortality, diabetes incidence, and cardiovascular events compared to usual care in obese patients over long-term follow-up.
For individuals with severe obesity (BMI >34-38 depending on sex), bariatric surgery is the most effective intervention for reducing long-term mortality and preventing type 2 diabetes and heart disease compared to lifestyle changes or medication alone. While surgery carries short-term risks, the long-term benefits in survival and disease prevention are substantial and sustained over decades.
Compared with usual care, bariatric surgery was associated with a long-term reduction in overall mortality ratio (HR) = 0.71... and decreased incidences of diabetes (adjusted HR=0.17)... myocardial infarction (adjusted HR = 0.71)... stroke (adjusted HR=0.66)... and cancer (women: adjusted HR = 0.58).
Why this rating
Prospective, controlled, long-term (up to 20 years) study with high follow-up rates for mortality data via national registers.
Source
Review of the key results from the Swedish Obese Subjects (<scp>SOS</scp>) trial – a prospective controlled intervention study of bariatric surgery
L. Sjöström · Journal of Internal Medicine · 2013
DOI 10.1111/joim.12012
More from this paper
- Bariatric surgery induces high rates of type 2 diabetes remission and prevention, with effects persisting for at least 10-15 years, although some relapse occurs over time.Strong
- High baseline insulin and/or glucose levels predict favorable treatment effects from bariatric surgery, whereas high baseline BMI does not.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →